IT1270122B - 6-benzil-4-ossopirimidine sostituite, processo per la loro preparazione e composizioni farmaceutiche che le contengono - Google Patents

6-benzil-4-ossopirimidine sostituite, processo per la loro preparazione e composizioni farmaceutiche che le contengono

Info

Publication number
IT1270122B
IT1270122B ITMI942023A ITMI942023A IT1270122B IT 1270122 B IT1270122 B IT 1270122B IT MI942023 A ITMI942023 A IT MI942023A IT MI942023 A ITMI942023 A IT MI942023A IT 1270122 B IT1270122 B IT 1270122B
Authority
IT
Italy
Prior art keywords
preparation
benzyl
pharmaceutical compositions
oxypyrimidin
replaced
Prior art date
Application number
ITMI942023A
Other languages
English (en)
Inventor
Marino Artico
Silvio Massa
Antonello Mai
Colla Paolo La
Maria Elena Marongiu
Enzo Tramontano
Original Assignee
Ist Superiore Sanita
Univ Cagliari
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ist Superiore Sanita, Univ Cagliari filed Critical Ist Superiore Sanita
Priority to ITMI942023A priority Critical patent/IT1270122B/it
Publication of ITMI942023A0 publication Critical patent/ITMI942023A0/it
Priority to PCT/EP1995/003912 priority patent/WO1996010565A1/en
Priority to AU38036/95A priority patent/AU3803695A/en
Publication of ITMI942023A1 publication Critical patent/ITMI942023A1/it
Application granted granted Critical
Publication of IT1270122B publication Critical patent/IT1270122B/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56One oxygen atom and one sulfur atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Sono descritte 6-benzil-4-ossopirimidine sostituite di formula (I) (FORMULA I) in cui:X è scelto nel gruppo costituito da O, S;R è scelto nel gruppo costituito da C1-4 alchile, C5-6 cicloalchile;R', R" e Z, uguali o diversi fra loro indicano H, C1-4 alchile considerando che quando X = O R ed R' non possono essere entrambi uguali a H;loro sali farmaceuticamente accettabili e loro derivati solubili;un loro processo di preparazione ed il loro uso per la preparazione di composizioni farmaceutiche utili per il trattamento di infezioni virali.
ITMI942023A 1994-10-04 1994-10-04 6-benzil-4-ossopirimidine sostituite, processo per la loro preparazione e composizioni farmaceutiche che le contengono IT1270122B (it)

Priority Applications (3)

Application Number Priority Date Filing Date Title
ITMI942023A IT1270122B (it) 1994-10-04 1994-10-04 6-benzil-4-ossopirimidine sostituite, processo per la loro preparazione e composizioni farmaceutiche che le contengono
PCT/EP1995/003912 WO1996010565A1 (en) 1994-10-04 1995-10-04 Substituted 6-benzyl-4-oxopyrimidines, process for their preparation and pharmaceutical compositions containing them
AU38036/95A AU3803695A (en) 1994-10-04 1995-10-04 Substituted 6-benzyl-4-oxopyrimidines, process for their preparation and pharmaceutical compositions containing them

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI942023A IT1270122B (it) 1994-10-04 1994-10-04 6-benzil-4-ossopirimidine sostituite, processo per la loro preparazione e composizioni farmaceutiche che le contengono

Publications (3)

Publication Number Publication Date
ITMI942023A0 ITMI942023A0 (it) 1994-10-04
ITMI942023A1 ITMI942023A1 (it) 1996-04-04
IT1270122B true IT1270122B (it) 1997-04-28

Family

ID=11369647

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI942023A IT1270122B (it) 1994-10-04 1994-10-04 6-benzil-4-ossopirimidine sostituite, processo per la loro preparazione e composizioni farmaceutiche che le contengono

Country Status (3)

Country Link
AU (1) AU3803695A (it)
IT (1) IT1270122B (it)
WO (1) WO1996010565A1 (it)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001007027A2 (en) * 1999-07-22 2001-02-01 Vertex Pharmaceuticals Incorporated Pyrimidine derivatives for the treatment of viral diseases
CN100439343C (zh) * 2006-08-04 2008-12-03 复旦大学 2-烷基硫-5-烷基-6-(1-氰基芳甲基)取代尿嘧啶类化合物及其制备方法和用途
CN100519540C (zh) * 2007-01-09 2009-07-29 云南大学 S-dabo类化合物、其合成方法和用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4612376A (en) * 1983-03-25 1986-09-16 Fujisawa Pharmaceutical Co., Ltd. Substituted-3,4-dihydro-4-(2,4,6-trimethoxyphenylimino)-2(1H)-pyrimidones useful as cardiotonic, antihypertensive, cerebrovascular vasodilator and anti-platelet agent
GB9012592D0 (en) * 1990-06-06 1990-07-25 Smithkline Beecham Intercredit Compounds

Also Published As

Publication number Publication date
AU3803695A (en) 1996-04-26
WO1996010565A1 (en) 1996-04-11
ITMI942023A0 (it) 1994-10-04
ITMI942023A1 (it) 1996-04-04

Similar Documents

Publication Publication Date Title
HUT61989A (en) Process for producing 2-deoxy-2,3-didehydro-n-acetylneuraminic acid derivatives and analogs, as well as pharmaceutical compositions comprising same as active ingredient
MD1233B1 (en) Erythromycin derivatives, process for their preparation and pharmaceutical composition on base thereof
AP9801378A0 (en) 9-amino-3- keto erythromycin derivatives.
HUT67398A (en) 1h-imidazo(4,5-c)quinolin-4-amin derivatives, pharmaceutical compositions containing them
BG103945A (bg) Производни на 4"-заместен-9-деоксо-9а-аза-9а- хомоеритромицин а
GR3026218T3 (en) Antiviral 4-substituted-2-deoxy-2,3-didehydro derivatives of alpha D-neuraminic acid
FI954898A0 (fi) Vesiliukoiset kamptotesiinijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö kasvaintenvastaisina aineina
DE3564566D1 (en) Quinone derivatives, method and use of preparing same, and pharmaceutical composition
TR199902995T2 (xx) 9-Oksim eritromisin t�revleri
IL95956A0 (en) Benzoic acid derivatives and pharmaceutical compositions containing the same
IL102814A0 (en) Pyrazine derivatives,their preparation and pharmaceutical compositions comprising them
AU656466B2 (en) New benzimidazole compounds, a process for their preparation and pharmaceutical compositions containing them
CA2286511A1 (en) Novel macrolide derivatives
NO933611L (no) Anti-tumor- og anti-psoriatiske midler
BR9611871A (pt) Diaminopirimidinas composições farmacêuticas contendo as mesmas e seu uso como antibactericidas
ATE259369T1 (de) Neue geranylgeranylderivate, verfahren zu deren herstellung und entsprechende pharmazeutische zusammensetzungen
KR950700310A (ko) 헤테로트리사이클릭 유도체, 그의 제조방법 및 그를 함유하는 약제학적 조성물(heterotricyclic derivatives, process for their preparation and pharmaceutical compositions containing them)
CA2127472A1 (en) New adenosine derivatives, preparation methods and pharmaceutical compositions containing them
UA48958C2 (uk) 9-o-оксимові похідні еритроміцину а та фармацевтична композиція на їх основі
DE69302829D1 (de) Bicyclische pyrimidinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische präparate
TW252979B (it)
IT1256623B (it) Antagonisti delle tachichinine, procedimento per la loro preparazione e loro impiego in formulazioni farmaceutiche
MX9806229A (es) Derivados de benzo(c)quinolicina, su preparacion y uso como inhibidores de la 5alfa-reductasas.
IT1270122B (it) 6-benzil-4-ossopirimidine sostituite, processo per la loro preparazione e composizioni farmaceutiche che le contengono
MY110004A (en) Biologically active ureido derivatives useful as antimetastatic agents.

Legal Events

Date Code Title Description
0001 Granted